REGENXBIO Inc. (RGNX) Social Stream



REGENXBIO Inc. (RGNX): $23.47

0.26 (+1.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RGNX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

REGENXBIO INC (RGNX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering REGENXBIO INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 9 $90 $43 $63.571 $23.21 173.89%
2022-01-10 8 $90 $29 $59.25 $23.21 155.28%
2022-02-01 8 $90 $29 $58.25 $23.21 150.97%
2022-02-14 8 $90 $29 $57.5 $23.21 147.74%
2022-03-04 8 $90 $25 $57 $23.21 145.58%
2022-03-22 7 $82 $25 $52.428 $23.21 125.89%
2022-03-29 7 $82 $25 $55.375 $23.21 138.58%
2022-04-11 8 $82 $25 $55.375 $23.21 138.58%
2022-05-06 8 $82 $25 $54.625 $23.21 135.35%
2022-06-10 8 $82 $25 $54.125 $23.21 133.2%
2022-07-11 10 $82 $25 $54.1 $23.21 133.09%
2022-08-04 10 $82 $25 $54.4 $23.21 134.38%
2022-08-31 10 $82 $25 $54.3 $23.21 133.95%
2022-10-03 8 $70 $25 $51.5 $23.21 121.89%
2022-10-04 9 $70 $25 $48.555 $23.21 109.2%
2022-10-25 9 $70 $13 $47.222 $23.21 103.46%
2022-11-04 9 $65 $13 $44.555 $23.21 91.96%
2022-11-06 9 $65 $14 $44.666 $23.21 92.44%
2022-11-21 9 $65 $14 $44.444 $23.21 91.49%
2022-11-30 9 $65 $15 $44.555 $23.21 91.96%
2022-12-15 9 $65 $15 $44 $23.21 89.57%
2023-01-27 9 $65 $14 $43.889 $23.21 89.1%

The Trend in the Analyst Price Target


RGNX's average price target has moved down $19.68 over the prior 15 months.

Over the past 51 weeks, RGNX's average upside potential has been 102.33%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-10 10 82 25 54.300 34.66 56.66%
2022-09-13 8 70 25 51.500 26.33 95.59%
2022-09-17 8 70 25 51.500 25.98 98.23%
2022-10-03 8 70 25 51.500 24.17 113.07%
2022-11-06 9 65 14 44.666 20.73 115.47%

RGNX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 6 0 3 0 0 9

The Trend in the Broker Recommendations


Over the past 39 weeks, RGNX's average broker recommendation rating improved by 0.21.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, REGENXBIO INC's variance in analysts' estimates is lower than -2016.71% of them.
  • REGENXBIO INC's upside potential (average analyst target price relative to current price) is greater than 1909.73% of all US stocks.
  • RGNX has a higher average analyst price target than 1685.09% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, REGENXBIO INC's number of analysts covering the stock is higher than 1624.33% of them.

Stocks similar to REGENXBIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FATE, IOVA, and NSTG.

Is RGNX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6526 seconds.